Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Sales | 7,364 | 5,388 | 3,835 | 4,543 | 2,584 |
| Cost of Goods | 3,486 | 2,586 | 2,751 | 2,999 | 4,902 |
| Gross Profit | 3,878 | 2,802 | 1,084 | 1,544 | -2,318 |
| Operating Expenses | 12,380 | 20,695 | 24,260 | 22,027 | 19,435 |
| Operating Income | -8,016 | -17,307 | -22,425 | -19,484 | -20,851 |
| Interest Expense | 9 | 437 | 1,016 | 956 | 172 |
| Other Income | -207 | 88 | 3,102 | 657 | -95 |
| Pre-tax Income | -8,232 | -17,656 | -20,339 | -19,783 | -21,118 |
| Net Income Continuous | -8,232 | -17,656 | -20,339 | -19,783 | -21,118 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -1,981 |
| Net Income | $-8,232 | $-17,656 | $-20,339 | $-19,783 | $-23,099 |
| EPS Basic Total Ops | -2,267.55 | -6,865.63 | -10,077.98 | -23,368.32 | -35,272.94 |
| EPS Basic Continuous Ops | -2,255.09 | -6,855.96 | -10,058.10 | -23,368.32 | -32,249.55 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -3,023.40 |
| EPS Diluted Total Ops | -2,267.55 | -6,865.63 | -10,077.98 | -23,368.32 | -35,272.94 |
| EPS Diluted Continuous Ops | -2,255.09 | -6,855.96 | -10,058.10 | -23,368.32 | -32,249.55 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -3,023.40 |
| EBITDA(a) | $-7,583 | $-16,539 | $-21,685 | $-18,812 | $-20,200 |